(Q46832044)

25 December 2017

title

Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003. (English)

1 reference

25 December 2017

main subject

gram-positive bacteria

0 references

4

Jones RN

1 reference

25 December 2017

author name string

Sader HS

series ordinal

1

1 reference

25 December 2017

Fritsche TR

series ordinal

2

1 reference

25 December 2017

Streit JM

series ordinal

3

1 reference

25 December 2017

publication date

1 October 2005

1 reference

25 December 2017

published in

Journal of Chemotherapy

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

page(s)

477-483

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Daptomycin in vitro susceptibility in European Gram-positive clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.477

10.1179/JOC.2005.17.5.477

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16323435

1 reference

25 December 2017